NATIONAL TAIPEI UNIVERSITY OF NURSING AND HEALTH SCIENCES

Xofluza Demonstrates Superior Efficacy Over Tamiflu in Reducing Hospitalizations and Emergency Department Visits

- A real-world study of 75,491 influenza patients found that Xofluza (baloxavir) significantly reduced hospitalization rates compared to Tamiflu (oseltamivir) across multiple time points. - At six months post-treatment, hospitalization rates were 0.8% for Xofluza versus 5.3% for Tamiflu, while emergency department visits were 5% versus 7.2% respectively. - The superior outcomes were most pronounced in female patients and those under 50 years of age, with no significant difference in mortality rates between treatments. - Researchers suggest baloxavir may help alleviate healthcare system burden during influenza seasons through reduced downstream complications requiring medical intervention.